Lipidomic analysis of human plasma reveals ether-linked lipids that are elevated in morbidly obese humans compared to lean

Diabetology and Metabolic Syndrome

Volumn 5, Issue 1, 2013, Pages

  Donovan, Elise L ^a,c   Pettine, Stefan M ^b   Hickey, Matthew S ^a   Hamilton, Karyn L ^a   Miller, Benjamin F ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b Heart Center of the Rockies   (United States)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Dyslipidemia; Endothelial cells; Lipidomics; Obesity; Oxidized phospholipids

Indexed keywords

CELL ADHESION MOLECULE; ETHER LIPID; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE;

ADULT; ARTICLE; BODY MASS; CELL ACTIVATION; CELL ADHESION; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LEAN BODY WEIGHT; LIPID ANALYSIS; OBESITY; PRIORITY JOURNAL;

EID: 84877608549     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-5-24     Document Type: Article

References (46)

1. Metabolic syndrome. Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R, Circulation 2005 111 1448 1454 10.1161/01.CIR.0000158483.13093.9D 15781756
2. Pathological aspects of lipid peroxidation. Negre-Salvayre A, Auge N, Ayala V, Basaga H, Boada J, Brenke R, Chapple S, Cohen G, Feher J, Grune T, Free Radic Res 2010 44 1125 1171 10.3109/10715762.2010.498478 20836660
3. Association between circulating oxidized Low-density lipoprotein and incidence of the metabolic syndrome. Holvoet P, Lee D-H, Steffes M, Gross M, Jacobs DR, JAMA 2008 299 2287 2293 10.1001/jama.299.19.2287 18492970
4. Association between oxidized LDL, obesity and type 2 diabetes in a population-based cohort, the health, aging and body composition study. Njajou OT, Kanaya AM, Holvoet P, Connelly S, Strotmeyer ES, Harris TB, Cummings SR, Hsueh W-C, Diabetes Metab Res Rev 2009 25 733 739 10.1002/dmrr.1011 19780064
5. Lipid homeostasis, lipotoxicity and the metabolic syndrome. Unger RH, Clark GO, Scherer PE, Orci L, Biochimica et Biophysica Acta (BBA) Molecular and Cell Biology of Lipids 2010 1801 209 214 10.1016/j.bbalip.2009.10.006
6. Determinants of bioactivity of oxidized phospholipids. Specific oxidized fatty acyl groups at the sn-2 position. Subbanagounder G, Leitinger N, Schwenke DC, Wong JW, Lee H, Rizza C, Watson AD, Faull KF, Fogelman AM, Berliner JA, Arterioscler Thromb Vasc Biol 2000 20 2248 2254 10.1161/01.ATV.20.10.2248 11031211
7. Endothelial cell regulation by phospholipid oxidation products. Berliner JA, Gharavi NM, Free Radic Biol Med 2008 45 119 123 10.1016/j.freeradbiomed. 2008.04.013 18460347
8. The role of oxidized phospholipids in atherosclerosis. Berliner JA, Leitinger N, Tsimikas S, J Lipid Res 2009 50 Suppl 207 S212 19059906
9. A role for oxidized phospholipids in atherosclerosis. Berliner JA, Watson AD, N Engl J Med 2005 353 9 11 10.1056/NEJMp058118 16000351
10. Inflammatory profile of oxidized phospholipids. Bochkov VN, Thromb Haemost 2007 97 348 354 17334500
11. Oxidized phospholipids in control of inflammation and endothelial barrier. Fu P, Birukov KG, Transl Res 2009 153 166 176 10.1016/j.trsl.2008.12. 005 19304275
12. Oxidized phospholipids as triggers of inflammation in atherosclerosis. Leitinger N, Mol Nutr Food Res 2005 49 1063 1071 10.1002/mnfr.200500086 16270279
13. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. Watson AD, Leitinger N, Navab M, Faull KF, Horkko S, Witztum JL, Palinski W, Schwenke D, Salomon RG, Sha W, J Biol Chem 1997 272 13597 13607 10.1074/jbc.272.21.13597 9153208
14. Lipid peroxidation of membrane phospholipids generates hydroxy-alkenals and oxidized phospholipids active in physiological and/or pathological conditions. Catala A, Chem Phys Lipids 2009 157 1 11 10.1016/j.chemphyslip.2008. 09.004 18977338
15. Remodeling of arachidonate-containing phosphoglycerides within the human neutrophil. Chilton FH, Murphy RC, J Biol Chem 1986 261 7771 7777 3086318
16. Preferential esterification of arachidonic acid into ethanolamine phospholipids in epithelial cells from ovine endometrium. Tamby JP, Reinaud P, Charpigny G, J Reprod Fertil 1996 107 23 30 10.1530/jrf.0.1070023 8699430
17. Plasmalogens the neglected regulatory and scavenging lipid species. Wallner S, Schmitz G, Chem Phys Lipids 2011 164 573 589 10.1016/j.chemphyslip. 2011.06.008 21723266
18. LDL from obese patients with the metabolic syndrome show increased lipid peroxidation and activate platelets. Colas R, Sassolas A, Guichardant M, Cugnet-Anceau C, Moret M, Moulin P, Lagarde M, Calzada C, Diabetologia 2011 54 2931 2940 10.1007/s00125-011-2272-8 21847583
19. Top-down lipidomics reveals ether lipid deficiency in blood plasma of hypertensive patients. Graessler J, Schwudke D, Schwarz PE, Herzog R, Shevchenko A, Bornstein SR, PLoS One 2009 4 6261 10.1371/journal.pone.0006261 19603071
20. Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. Matyash V, Liebisch G, Kurzchalia TV, Shevchenko A, Schwudke D, J Lipid Res 2008 49 1137 1146 10.1194/jlr.D700041-JLR200 18281723
21. OPLS discriminant analysis: combining the strengths of PLS-DA and SIMCA classification. Bylesj M, Holmes E, Trygg J, Rantalainen M, Cloarec O, Nicholson JK, J Chemometr 2006 20 341 351 10.1002/cem.1006
22. LIPID MAPS online tools for lipid research. Fahy ESM, Cotter D, Subramaniam S, LIPID MAPS Online Tools 2007 35 606 W612
23. Comprehensive LC-MS E lipidomic analysis using a shotgun approach and its application to biomarker detection and identification in osteoarthritis patients. Castro-Perez JM, Kamphorst J, DeGroot J, Lafeber F, Goshawk J, Yu K, Shockcor JP, Vreeken RJ, Hankemeier T, J Proteome Res 2010 9 2377 2389 10.1021/pr901094j 20355720
24. Peripheral ethanolamine plasmalogen deficiency: a logical causative factor in Alzheimer's disease and dementia. Goodenowe DB, Cook LL, Liu J, Lu Y, Jayasinghe DA, Ahiahonu PW, Heath D, Yamazaki Y, Flax J, Krenitsky KF, J Lipid Res 2007 48 2485 2498 10.1194/jlr.P700023-JLR200 17664527
25. Identification of abundant alkyl ether glycerophospholipids in the human lens by tandem mass spectrometry techniques. Deeley JM, Thomas MC, Truscott RJ, Mitchell TW, Blanksby SJ, Anal Chem 2009 81 1920 1930 10.1021/ac802395d 19186979
26. Comparison of lipid and fatty acid composition of the liver, subcutaneous and intra-abdominal adipose tissue, and serum. Kotronen A, Seppanen-Laakso T, Westerbacka J, Kiviluoto T, Arola J, Ruskeepaa AL, Yki-Jarvinen H, Oresic M, Obesity (Silver Spring) 2010 18 937 944 10.1038/oby.2009.326
27. Identification of atypical ether-linked glycerophospholipid species in macrophages by mass spectrometry. Ivanova PT, Milne SB, Brown HA, J Lipid Res 2010 51 1581 1590 10.1194/jlr.D003715 19965583
28. Acquired obesity is associated with changes in the serum lipidomic profile independent of genetic effects-a monozygotic twin study. Pietilainen KH, Sysi-Aho M, Rissanen A, Seppanen-Laakso T, Yki-Jarvinen H, Kaprio J, Oresic M, PLoS One 2007 2 218 10.1371/journal.pone.0000218 17299598
29. LDL from obese patients with the metabolic syndrome show increased lipid peroxidation and activate platelets. Colas R, Sassolas A, Guichardant M, Cugnet-Anceau C, Moret M, Moulin P, Lagarde M, Calzada C, Diabetologia 2011 54 2931 2940 10.1007/s00125-011-2272-8 21847583
30. Plasmalogen levels in serum from patients with impaired carbohydrate or lipid metabolism and in elderly subjects with normal metabolic values. Brosche T, Arch Gerontol Geriatr 2001 32 283 294 10.1016/S0167-4943(01)00105-4 11395174
31. Plasma plasmalogens of the phosphoethanolamine type and angiopathy in diabetic patients. Goto I, Antoku Y, Hayakawa T, Klin Wochenschr 1990 68 49 10.1007/BF01648892 2308268
32. Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry. Han X, Holtzman DM, McKeel DW Jr, J Neurochem 2001 77 1168 1180 10.1046/j.1471-4159.2001.00332.x 11359882
33. HOCl-mediated glycerophosphocholine and glycerophosphoethanolamine generation from plasmalogens in phospholipid mixtures. Lessig J, Fuchs B, Lipids 2010 45 37 51 10.1007/s11745-009-3365-8 19937395
34. Plasmalogen phospholipids as potential protectors against lipid peroxidation of low density lipoproteins. Engelmann B, Brautigam C, Thiery J, Biochem Biophys Res Commun 1994 204 1235 1242 10.1006/bbrc.1994.2595 7980601
35. Lipoproteins secreted by cultured rat hepatocytes contain the antioxidant 1-alk-1-enyl-2-acylglycerophosphoethanolamine. Vance JE, Biochim Biophys Acta 1990 1045 128 134 10.1016/0005-2760(90)90141-J 2116174
36. Susceptibility of plasmenyl glycerophosphoethanolamine lipids containing arachidonate to oxidative degradation. Khaselev N, Murphy RC, Free Radic Biol Med 1999 26 275 284 10.1016/S0891-5849(98)00211-1 9895217
37. PLA2 Mediated arachidonate free radicals: PLA2 inhibition and neutralization of free radicals by anti-oxidants-a new role as anti-inflammatory molecule. Nanda BL, Nataraju A, Rajesh R, Rangappa KS, Shekar MA, Vishwanath BS, Curr Top Med Chem 2007 7 765 777 10.2174/156802607780487623 17456040
38. Prostaglandins and inflammation. Ricciotti E, FitzGerald GA, Arterioscler Thromb Vasc Biol 2011 31 986 1000 10.1161/ATVBAHA.110.207449 21508345
39. Oxidized LDL and lysophosphatidylcholine stimulate plasminogen activator inhibitor-1 expression through reactive oxygen species generation and ERK1/2 activation in 3T3-L1 adipocytes. Kuniyasu A, Tokunaga M, Yamamoto T, Inoue S, Obama K, Kawahara K, Nakayama H, Biochim Biophys Acta 2011 1811 153 162 10.1016/j.bbalip.2010.11.011 21146630
40. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. Kume N, Cybulsky MI, Gimbrone MA Jr, J Clin Invest 1992 90 1138 1144 10.1172/JCI115932 1381720
41. Lysophospholipids increase ICAM-1 expression in HUVEC through a Gi- and NF-kappaB-dependent mechanism. Lee H, Lin CI, Liao JJ, Lee YW, Yang HY, Lee CY, Hsu HY, Wu HL, Am J Physiol Cell Physiol 2004 287 1657 C1666 10.1152/ajpcell.00172.2004 15294853
42. Phospholipid mediators in the vessel wall: involvement in atherosclerosis. Ninio E, Curr Opin Clin Nutr Metab Care 2005 8 123 131 10.1097/00075197-200503000-00004 15716789
43. Relationship of lipoprotein-associated phospholipase A2 and oxidized low-density lipoprotein in carotid atherosclerosis. Vickers KC, Maguire CT, Wolfert R, Burns AR, Reardon M, Geis R, Holvoet P, Morrisett JD, J Lipid Res 2009 50 1735 1743 10.1194/jlr.M800342-JLR200 19359705
44. Plasma phospholipid metabolic profiling and biomarkers of type 2 diabetes mellitus based on high-performance liquid chromatography/electrospray mass spectrometry and multivariate statistical analysis. Wang C, Kong H, Guan Y, Yang J, Gu J, Yang S, Xu G, Anal Chem 2005 77 4108 4116 10.1021/ac0481001 15987116
45. Metabolic profiling of plasma in overweight/obese and lean men using ultra performance liquid chromatography and Q-TOF mass spectrometry (UPLC-Q-TOF MS). Kim JY, Park JY, Kim OY, Ham BM, Kim HJ, Kwon DY, Jang Y, Lee JH, J Proteome Res 2010 9 4368 4375 10.1021/pr100101p 20560578
46. Metabolite profiling identifies candidate markers reflecting the clinical adaptations associated with roux-en-Y gastric bypass surgery. Mutch DM, Fuhrmann JC, Rein D, Wiemer JC, Bouillot JL, Poitou C, Clement K, PLoS One 2009 4 7905 10.1371/journal.pone.0007905 19936240